Companies that own Opthea Ltd.
BVF Partners LP
33,281,585
16.41%
0
1.01%
07/28/2017
Regal Funds Management Pty Ltd.
17,888,870
8.82%
5,076,667
1.18%
05/28/2018
Baker Bros. Advisors LP
16,385,959
8.08%
2,848,201
0.05%
12/15/2017
FIL Investment Management (Singapore) Ltd.
2,568,616
1.27%
-51,545
0.01%
05/31/2018
Union Investment Privatfonds GmbH
1,000,000
0.49%
-4,000,000
0%
03/31/2018
Schröder Equities GmbH
575,778
0.28%
0
1.83%
06/29/2018
FIL Investment Management (Hong Kong) Ltd.
328,158
0.16%
-24,144
0%
03/31/2018
FIL Investment Advisors (UK) Ltd.
62,083
0.03%
922
0%
03/31/2018
DWS Investment GmbH
0
0%
-6,636,208
0%
06/29/2018
| Address |
650 Chapel Street
South Yarra Victoria (VIC) 3141
Australia
|
|
Employees
|
- |
| Website |
http://www.opthea.com |
| Updated |
07/08/2019 |
| Opthea Ltd. is engaged in developing biological therapeutics for cancer and other serious diseases. It is a biologics drug developer building on its significant intellectual property portfolio around Vascular Endothelial Growth Factor C and D angiogenic molecules and R3. The company focuses on vascular endothelial growth factors to develop truly novel therapies to extend and improve the lives of cancer sufferers. |
